This site is intended for healthcare professionals only
LoginRegister
No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUNNo Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars 'ABSUN'
Alembic Pharma Sets Up Germany Arm to Expand European Market PresenceAlembic Pharma Sets Up Germany Arm to Expand European Market Presence
Former GlaVellaian Karuppiah Joins Shilpa Medicare as COOShilpa Medicare Names Pharma Veteran Vellaian Karuppiah as COO, Formulations
WHOIn a First, WHO Approves Artemether-Lumefantrine for Infants with Malaria
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss EntryRoche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry
State Drug Alert: From Antibiotics to Antihypertensives, 134 Samples Found NSQ in February AuditState Drug Alert: 141 Medicine Samples Fail CDSCO Quality Tests in March
No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUNSun Pharma Submits Binding USD 13 Billion Bid for Organon, Deal May Be India's Largest Pharma...
Alembic Enters Philippines Market with New Subsidiary for Pharma DistributionAlembic Enters Philippines Market with New Subsidiary for Pharma Distribution
OneSource Strengthens CDMO Play as Partner Secures USFDA Tentative Approval for Ozempic GenericOneSource Strengthens CDMO Play as Partner Secures USFDA Tentative Approval for Ozempic Generic
Fake Mounjaro in GurugramTypo Errors, Colour Mismatch Lead to Bust of Fake Mounjaro in Gurugram
AbbVieAbbVie Faces Setback as USFDA Declines Approval of Wrinkle Drug TrenibotE
CiplaCipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio
X